|
In a move that we believe will add meaningful value to the overall company, Plandaí¬ Biotechnology, Inc. (OTCQB – PLPL - $0.51 – Spec Buy) recently announced that it has formed a new wholly-owned subsidiary, Cannabis Biosciences, Inc., to develop and test a new Phytofare™ botanical extract derived from cannabis.
|
|
Read more...
|
|
Much like in the 1970’s and 1980’s when growth in the popularity of tennis was driven by major names such as Jimmy Conners, John McEnroe, Ivan Lendl, and Martina Navratilova, history is repeating itself.
|
|
Read more...
|
|
Savvy traders and followers of Nuvilex, Inc. (OTCQB – NVLX - $0.114 – Spec Buy), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases can sense that a return to much higher levels is brewing.
|
|
Read more...
|
|
Laredo Resources, Inc.appears to be on the verge of cashing in on some of the material found on the patented claims on its site in southwestern Montana, which would have a major positive impact on the value of the company’s stock.
|
|
Read more...
|
|
Gold prices have reached a 5 week high and appear primed to continue their rise. In response, a number of mining stocks are under serious accumulation including Laredo Resources Corp. (OTCQB – LRDR), our latest Speculative Buy recommendation.
Leveraging the historical mining successes in the region and on the site itself, Laredo Resources Corp. appears poised to take advantage of one of the most attractive mining opportunities in the Northwest region of the United States.
The Pony Mountain Gold site is located in the Mineral Hills District in southwestern Montana. The property is a proven producer of gold dating back to the 1800’s.
With approximately 100,000 tons of dump material on the site that could produce gold, the size of the near term opportunity is simply huge.
With a long history of mining success on the property as well as major finds by mining leaders like Barrick Gold on adjacent properties, we believe that the undervalued Laredo offers great potential. As management executes its very achievable and conservative operations plan, these shares are likely to spike higher.
|
|
Read more...
|
|
In early 2014, the Company will launch a trial to test anti-aging properties of its topical cream delivered offering.
|
|
Read more...
|
|
LifeApps has won acclaim for its digital offerings and via its recent acquisition of Sports One and the introduction of the Golf Core Grip System, management is gaining real sales traction
|
|
Read more...
|
|
In the near term, the pending 3Q13 financial report from Celgene (NASDAQ - CELG), which is due later this week, will place further attention on the pancreatic cancer treatment sector, and by association, Nuvilex.
|
|
Read more...
|
|
|
|
|
<< Start < Prev 21 22 23 24 25 26 27 28 29 30 Next > End >>
|
|
Page 24 of 39 |
